Immuneering uses bioinformatically tuned target identification and hit finding platforms to generate drug candidates that can tamp down aberrant signalling. The post Disease Cancelling Technology Emulates...
Where conventional mass spec struggles with sequencing and the recognition of isoforms and post-translational modifications, new technologies may shine. The post Proteomics Begins to Emerge from...
In 2021, so far, Moderna (MRNA) has continued last year’s performance. Shares are already up 66% this year
Much of the attention on Pfizer, BioNTech, Moderna, Johnson & Johnson and AstraZeneca has been on their Covid-19 vaccine efforts, and here is a look at what else...
Vir Biotechnology, Eli Lilly and GlaxoSmithKline struck a three-way collaborative deal to evaluate Vir's investigational monoclonal antibody VIR-7831 in combination with Lilly’s bamlanivimab in low-risk patients with mild...
Scientists in Australia developed a method for the rapid, safe synthesis of highly pure protein-based vaccines for respiratory pathogens, which can be taken straight into animal...
Researchers are working on a type of vaccine technology using nanoparticles that is less expensive and does not need to be stored at very low temperatures...
Seattle-based AltPep Corporation raised $23.15 million in a Series A financing round to take the company's breakthrough amyloid targeting platform to development.
Sana Biotechnology is one of those startups that was sketched in on the chalkboard day one in the shape of a unicorn. A giant unicorn. And...
BioSpace looks at some of the top stories from Day 2 of the virtual JP Morgan Annual Healthcare Conference.
Credit: Cody Duty/UTHealth Researchers evaluating whether an investigational oral drug, vadadustat, can help prevent acute respiratory distress syndrome (ARDS) in COVID-19 patients were awarded $5.1 million...
Drugmaker GSK and Vir Biotechnology will evaluate a second antibody-based treatment in patients with mild to moderate COVID-19
ImmunityBio has licensed technology underpinning a COVID-19 vaccine that could be administered orally rather than by injection from The post Oral COVID-19 vaccine beckons, as ImmunityBio...
Lead candidates described in Science publication Credit: © DiosCURE Therapeutics Core technology includes promising bivalent single-domain antibodies simultaneously targeting two surface structures of the viral spike...
Following reports from Joe Biden’s transition team that the President-elect is planning to release nearly every available dose of Covid-19 vaccines when he takes office, the...
CNBC Exclusive: CNBC Transcript: BioNTech CEO Dr. Ugur Sahin speaks with CNBC’s “Squawk Box” today about Pfizer-BioNTech coronavirus vaccine being effective against new mutation strains in...
A little less than two years after bagging an extended $50 million Series C, IsoPlexis and its “proteomic barcodes” for personalized cancer care are back setting...
COVID-19 has compressed bioprocessing timelines, leaving no room for uncertainty in the characterization of raw materials and contaminants. The post Bioprocessing in a Post-COVID-19 World appeared...
New solutions in biomedical research are propelling the field by leaps and bounds ahead of what was accomplished in decades past. Biotechnology and particularly genome engineering...
While biopharma was dominated by COVID-19, which prompted a surge of research and business activity, the industry also saw developments that will position it for further...
Boston area biotech Werewolf Therapeutics launched in late 2019 with the goal of chasing novel immune system modulators to eradicate solid tumors. Just over a year...
A new year, a new addition to the stock portfolio – what can make more sense than that? The right time to buy, of course, is...
Arcturus Therapeutics (ARCT) investors felt the impact of a thunderous thud on Tuesday, following the share price’s collapse. The stock shed over 50% of its value...
Russia Developing "Highly Efficient Antidote" To Fight COVID, Preclinical Tests Show 99% Effectiveness Russia is using its vaccine program for soft power diplomacy. On Tuesday, Argentina and Belarus...
Shares of Hepion Pharmaceuticals exploded 47% in Wednesday’s pre-market trading after the biopharma company released “positive” top line trial results for its oral inhibitor used in...
As Arcturus Therapeutics charges full speed into a Phase II trial for its single-dose Covid-19 vaccine in Singapore, some analysts say weak Phase I/II data point...
Arcturus Therapeutics announced that the Singapore Health Sciences Authority approved the start of the Phase 2 clinical study of its COVID-19 vaccine candidate ARCT-021.
These tickers changing hands for less than $5 per share either draw investors in with their high return potential or send them running.
Shares of IMV Inc. jumped 13% in Monday’s pre-market trading after the clinical-stage biopharma company announced positive results for its COVID-19 vaccine
Insiders are an interesting lot. From an investor’s perspective, corporate officers have access to information – and information has always been the key to successful investing.